Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mylan To Enter Japanese Market , CEO Says

This article was originally published in PharmAsia News

Executive Summary

American generic drug giant Mylan plans to expand into the Japanese market, Mylan CEO Robert J Coury announced during a press briefing in Tokyo. Coury said that Mylan will take Japanese market needs into consideration and start by supplying drug materials to Japanese pharmaceutical companies. Regarding a possible buyout of a Japanese generic drug maker, Coury commented that Mylan considers it as one option, but that an acquisition is not the only way to capture market share. Ranked as the world's number three generic drug maker, Mylan has commercial operations in 92 countries and sales of $4.2 billion in 2007. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts